Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 5
2001 2
2002 1
2003 5
2004 9
2005 11
2006 13
2007 50
2008 10
2009 10
2010 9
2011 15
2012 17
2013 33
2014 34
2015 36
2016 16
2017 14
2018 14
2019 20
2020 13
2021 30
2022 36
2023 21
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Results by year

Filters applied: . Clear all
Page 1
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM; PRECISION Study Group Collaborators. Kasivisvanathan V, et al. Among authors: ruffion a. N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18. N Engl J Med. 2018. PMID: 29552975 Free PMC article. Clinical Trial.
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.
Ploussard G, Fiard G, Barret E, Brureau L, Créhange G, Dariane C, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Rozet F, Ruffion A, Sargos P, Beauval JB, Rouprêt M. Ploussard G, et al. Among authors: ruffion a. Prog Urol. 2022 Nov;32(15):1275-1372. doi: 10.1016/j.purol.2022.07.148. Prog Urol. 2022. PMID: 36400483 Review.
[Editorial].
Ruffion A. Ruffion A. Prog Urol. 2019 Mar;29(3):133. doi: 10.1016/j.purol.2019.01.002. Epub 2019 Feb 26. Prog Urol. 2019. PMID: 30819631 French. No abstract available.
A Multicenter, Randomized, Placebo-Controlled Study Evaluating the Efficacy of a Combination of Propolis and Cranberry (Vaccinium macrocarpon) (DUAB®) in Preventing Low Urinary Tract Infection Recurrence in Women Complaining of Recurrent Cystitis.
Bruyère F, Azzouzi AR, Lavigne JP, Droupy S, Coloby P, Game X, Karsenty G, Issartel B, Ruffion A, Misrai V, Sotto A, Allaert FA. Bruyère F, et al. Among authors: ruffion a. Urol Int. 2019;103(1):41-48. doi: 10.1159/000496695. Epub 2019 May 22. Urol Int. 2019. PMID: 31117097 Clinical Trial.
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, Decaussin-Petrucci M, Dubreuil-Chambardel M, Magaud L, Remontet L, Ruffion A, Colombel M, Crouzet S, Schott AM, Lemaitre L, Rabilloud M, Grenier N; MRI-FIRST Investigators. Rouvière O, et al. Among authors: ruffion a. Lancet Oncol. 2019 Jan;20(1):100-109. doi: 10.1016/S1470-2045(18)30569-2. Epub 2018 Nov 21. Lancet Oncol. 2019. PMID: 30470502
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Carrie C, Magné N, Burban-Provost P, Sargos P, Latorzeff I, Lagrange JL, Supiot S, Belkacemi Y, Peiffert D, Allouache N, Dubray BM, Servagi-Vernat S, Suchaud JP, Crehange G, Guerif S, Brihoum M, Barbier N, Graff-Cailleaud P, Ruffion A, Dussart S, Ferlay C, Chabaud S. Carrie C, et al. Among authors: ruffion a. Lancet Oncol. 2019 Dec;20(12):1740-1749. doi: 10.1016/S1470-2045(19)30486-3. Epub 2019 Oct 16. Lancet Oncol. 2019. PMID: 31629656 Clinical Trial.
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis.
Baboudjian M, Rajwa P, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G; Prostate Cancer Committee of the Association Française d'Urologie CC-AFU. Baboudjian M, et al. Among authors: ruffion a. Eur Urol Open Sci. 2022 May 19;41:35-44. doi: 10.1016/j.euros.2022.04.012. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35633829 Free PMC article. Review.
Neurologic urinary incontinence.
Wyndaele JJ, Kovindha A, Madersbacher H, Radziszewski P, Ruffion A, Schurch B, Castro D, Igawa Y, Sakakibara R, Wein A; Committe 10 on Neurogenic Bladder and Bowel of the International Consultation on Incontinence 2008-2009. Wyndaele JJ, et al. Among authors: ruffion a. Neurourol Urodyn. 2010;29(1):159-64. doi: 10.1002/nau.20852. Neurourol Urodyn. 2010. PMID: 20025021 Review.
Neurologic fecal incontinence.
Wyndaele JJ, Kovindha A, Igawa Y, Madersbacher H, Radziszewski P, Ruffion A, Schurch B, Castro D, Sakakibara R, Wein A; ICI 2009 Committee 10. Wyndaele JJ, et al. Among authors: ruffion a. Neurourol Urodyn. 2010;29(1):207-12. doi: 10.1002/nau.20853. Neurourol Urodyn. 2010. PMID: 20025022 Review.
362 results